PPARA polymorphism influences the cardiovascular benefit of fenofibrate in type 2 diabetes: Findings from accord-lipid

Mario Luca Morieri, Hetal S. Shah, Jennifer Sjaarda, Petra A. Lenzini, Hannah Campbell, Alison A. Motsinger-Reif, He Gao, Laura Lovato, Sabrina Prudente, Assunta Pandolfi, Marcus G. Pezzolesi, Ronald J. Sigal, Guillaume Paré, Santica M. Marcovina, Daniel M. Rotroff, Elisabetta Patorno, Luana Mercuri, Vincenzo Trischitta, Emily Y. Chew, Peter KraftJohn B. Buse, Michael J. Wagner, Sharon Cresci, Hertzel C. Gerstein, Henry N. Ginsberg, Josyf C. Mychaleckyj, Alessandro Doria

Research output: Contribution to journalArticlepeer-review

24 Scopus citations

Fingerprint

Dive into the research topics of 'PPARA polymorphism influences the cardiovascular benefit of fenofibrate in type 2 diabetes: Findings from accord-lipid'. Together they form a unique fingerprint.

Medicine & Life Sciences